Published ahead of print on June 25, 2010
doi: 10.3174/ajnr.A2172
American Journal of Neuroradiology 31:E72, September 2010
© 2010 American Society of Neuroradiology
M. Savoiardoa and M. Grisolia
aDepartment of Neuroradiology
Foundation IRCCS Istituto Neurologico Carlo Besta
Milan, Italy
We greatly appreciated the excellent review of superficial siderosis (SS) by Kumar.1 Regarding a few details, however, we do not share the same view.
One is the presence of “calcifications at sites of hemosiderin deposition around the brain stem,” responsible for a rim of hyperattenuation sometimes seen on CT. Kumar1 attributes this interpretation (calcium for high densities) to our previous article published in the American Journal of Neuroradiology in 1993.2 Actually, in that article, we considered this hyperattenuation “compatible with … hemosiderin” on the basis of several accurate pathologic studies carried out by Koeppen and Dentinger,3 also quoted by Kumar. As in hemochromatosis, iron is sufficient to justify the hyperattenuation, without necessarily invoking calcium that, as far as we know, has never been described in SS.
The second point deals with the involvement of cranial nerves. Because the active mechanism of transforming blood by-products into hemosiderin and ferritin described by Koeppen and Dentinger3 requires the presence of central myelin (ie, of glial cells), the nerves involved should be the first, second, and eighth: the first and second because they are part of the central nervoussystem, the eighth because the transition from central to peripheral myelin (produced by Schwann cells) is known to occur in the acoustic canal, more than 10 mm from the entrance into the brain stem. For the other cranial nerves (and spinal roots), the transition is within 0.5–1 mm from the brain stem (and spinal cord). See Fig 1 for the first cranial nerve and illustrations from previous articles for the other cranial nerves and spinal roots.2,4,5 In a case of SS we recently observed, however, the loss of signal intensity along the trigeminal root extending for a few millimeters along the cisternal segment; it has been demonstrated that in this root, the central myelin–peripheral myelin transitional zone is not always so close to the brain stem as is usually considered, but it may be found up to 6–7 mm from the brain stem. In good-quality studies, the seventh nerve, in our experience, is always normal, in contrast to the T2 or T2* hypointensity of the eighth nerve.4 (See also Fig 6 in the article by Koeppen and Dentinger.3) In summary, the T2 hypointensity on the brain and spinal cord surface and along the short initial segment of the nerves and roots where central myelin is present perfectly corresponds to the histologic and immunocytochemical observations made by Koeppen and Dentinger.3
|
An interesting feature of SS of the cranial nerves is that there is a clinical discrepancy between olfactory, visual, and acousticinvolvement. The explanation is simple: Deafness severely impairs the patient’s daily life. Loss of smell and impairment of peripheral vision (macular fibers are centrally located in the optic nerve and therefore not affected) are much better tolerated and sometimes not even tested by the neurologist but are, indeed, present.2
Finally, in mentioning the association of SS with dural defects, spinal epidural collections, and dural enhancement, Kumar also refers to spontaneous intracranial hypotension (SIH) using the term “CSF hypovolemia.” We think that this term is a misnomer.6 As we already pointed out, “hypovolemia” means decreased volume of blood, whereas in SIH, in agreement with the Monro-Kellie doctrine, the venous blood is increased to compensate for the loss of CSF, as manifested by dilation of venous sinuses, engorgement of the pituitary gland, and dilation of spinal epidural venous plexus.6 The correct term (according to Stedman’s Medical Dictionary, Lippincott, Williams & Wilkins, 2006) should be “CSF hypovolia,” but “hypovolia” has never been used and may be a potential source of confusion. If we want to emphasize the leakage of CSF rather than its decreased pressure, we prefer using the expression “CSF loss of volume,” which certainly is correct, clear, andunambiguous.
References
- Kumar N. Neuroimaging in superficial siderosis: an in-depth look. AJNR Am J Neuroradiol 2010;31:5–14[Abstract/Free Full Text]
- Bracchi M, Savoiardo M, Triulzi F, et al. Superficial siderosis of the CNS: MR diagnosis and clinical findings. AINR Am J Neuroradiol 1993;14:227–36
- Koeppen AH, Dentinger MP. Brain hemosiderin and superficial siderosis of the central nervous system. J Neuropathol Exp Neurol 1988;47:249–70[Medline]
- Grisoli M, Maccagnano E, De Simone T, et al. Superficial siderosis of the CNS: selective central myelin vulnerability and peripheral myelin sparing demonstrated by MRI. Eur J Neurol 2007;14:e2–e3[Medline]
- Savoiardo M, Grisoli M, Pareyson D. Polyradiculopathy in the course of superficial siderosis of the CNS. J Neurol2001;248:1099–100[Medline]
- Savoiardo M, Armenise S, Spagnolo P, et al. Dural sinus thrombosis in spontaneous intracranial hypotension: hypotheses on possible mechanisms. J Neurol 2006;53:1197–202
Reply
Published ahead of print on June 25, 2010
doi: 10.3174/ajnr.A2187
American Journal of Neuroradiology 31:E73, September 2010
© 2010 American Society of Neuroradiology
N. Kumara
aMayo Clinic
Rochester, Minnesota
I thank Drs Savoiardo and Grisoli for adding to my Review Article on neuroimaging in superficial siderosis by providing 3 MR imaging illustrations of olfactory nerve involvement in this condition. I agree that anosmia and impaired peripheral vision may be under-reported symptoms.
“CSF hypovolemia” would mean decreased volume of CSF, and this term is preferred to “craniospinal hypotension” because a reduced CSF pressure may not describe the pathophysiology of the spectrum of abnormalities noted with dural defects.1,2
Hereditary hemochromatosis is unlikely to cause neurologic manifestations.3To my knowledge, there is limited information to confirm the suggestion that the hyperattenuation seen on head CT in some patients with superficial siderosis is due to iron and not calcium. High-definition x-ray fluorescence mapping and spectroscopy of siderotic spinal cord tissue has not shown the presence of calcium.4 In many patients with superficial siderosis, no abnormality is noted on CT. Furthermore, many of the conditions associatedwith primary brain iron accumulation (neurodegeneration with brain iron accumulation) do not have abnormalities on CT, despite striking changes on brain MR imaging, particularly on gradient-echo sequences.5
References
- Mokri B. Spontaneous cerebrospinal fluid leaks: from intracranial hypotension to cerebrospinal fluid hypovolemia—evolution of a concept. Mayo Clin Proc 1999;74:1113–23[Abstract/Free Full Text]
- Miyazawa K, Shiga Y, Hasegawa T, et al. CSF hypovolemia vs intracranial hypotension in “spontaneous intracranial hypotension syndrome.” Neurology 2003;60:941–47[Abstract/Free Full Text]
- Russo N, Edwards M, Andrews T, et al. Hereditary haemochromatosis is unlikely to cause movement disorders: a critical review. J Neurol 2004;251:849–52[CrossRef][Medline]
- Koeppen AH, Michael SC, Li D, et al. The pathology of superficial siderosis of the central nervous system. Acta Neuropathol 2008;116:371–82. Epub 2008 Aug 12[CrossRef][Medline]
- McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;70:1614–19[Abstract/Free Full Text]